Cleveland Clinic CEO Worries Comparative Effectiveness Could Stifle Innovation


Published On: August 21st, 2010

People worry not so much about the research itself, but what the government or insurance companies do with it.

Read the original:
Cleveland Clinic CEO Worries Comparative Effectiveness Could Stifle Innovation

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


In 2003, HIV and AIDS was the leading cause of death for African-American women between 25 and 34 years of age. The rate of HIV diagnosis among African-American women was 25 times that of white women, and African-American men were eight times more likely than their white counterparts to be diagnosed with HIV

Related Posts

  • Candidates Aplenty for Spending on Comparative Effectiveness
    Earlier this year, the National Institutes of Health came up with a priority list of projects that should get priority for the $1.1 billion in research funding included in the economic stimulus package. Today, the Institute of Medicine issued its own recommendations for the 100 health topics it thinks should get funding. Like the NIH’s..
  • Cancer Field ‘Conundrum’: Comparative Effectiveness Research
    A Duke oncologist is warning that the emphasis on comparative effectiveness studies may present obstacles for the field of cancer research, Scientific American’s Observations blog reports . ..
  • Baucus: Don’t Like Comparative Effectiveness? Meet ‘Fred’
    Most everybody wants the best deal for the money, but not everybody wants to settle for some potential options being excluded from the deal–no matter the cost of those options. So it goes in the continuing debate over comparative effectiveness research in health care. ..
  • Cardiologist, Cleveland Clinic Settle Suit Over Firing
    A joint statement says the clinic acknowledges that Yadav did disclose an interest in the sale of Angioguard and that an independent review “concluded that the integrity of Dr. Yadav’s research” wasn’t compromised by his financial relationships. ..
  • PhRMA Tries to Keep ‘Comparative Effectiveness’ in Check
    The drug industry is taking it up a notch in its push against the idea of comparing the effectiveness of drugs and using the information to make insurance-coverage decisions. The industry has been offering mixed messages about “comparative effectiveness,” supporting the general concept of comparing new drugs with existing ones, as long as the information..
  • Kerry: Tax on Medical-Device Makers Could Derail Innovation
    Sen. John Kerry hasn’t been shy about supporting new taxes to pay for the health-care overhaul ..
Leave a comment
Comments are closed.
« Health Blog Q&A: Retiring Fred Hutchinson Head Lee Hartwell FBI Agent, 19 Others Vote Against Jazz Pharma’s Drug For Fibromyalgia »